Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.
about
Decreased camptothecin sensitivity of the stem-cell-like fraction of Caco2 cells correlates with an altered phosphorylation pattern of topoisomerase IThe anticancer effect of (1S,2S,3E,7E,11E)-3,7,11, 15-cembratetraen-17,2-olide(LS-1) through the activation of TGF-β signaling in SNU-C5/5-FU, fluorouracil-resistant human colon cancer cells.Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells.Nucleotide excision repair and response and survival to chemotherapy in colorectal cancer patients.The irinotecan/5-fluorouracil combination induces apoptosis and enhances manganese superoxide dismutase activity in HT-29 human colon carcinoma cells.E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.
P2860
Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Irinotecan and oxaliplatin: an ...... of advanced colorectal cancer.
@ast
Irinotecan and oxaliplatin: an ...... of advanced colorectal cancer.
@en
Irinotecan and oxaliplatin: an ...... of advanced colorectal cancer.
@nl
type
label
Irinotecan and oxaliplatin: an ...... of advanced colorectal cancer.
@ast
Irinotecan and oxaliplatin: an ...... of advanced colorectal cancer.
@en
Irinotecan and oxaliplatin: an ...... of advanced colorectal cancer.
@nl
prefLabel
Irinotecan and oxaliplatin: an ...... of advanced colorectal cancer.
@ast
Irinotecan and oxaliplatin: an ...... of advanced colorectal cancer.
@en
Irinotecan and oxaliplatin: an ...... of advanced colorectal cancer.
@nl
P2093
P2860
P1476
Irinotecan and oxaliplatin: an ...... of advanced colorectal cancer.
@en
P2093
G J Peters
G Schwartsmann
I Grivicich
P2860
P304
P356
10.1590/S0100-879X2001000900001
P407
P577
2001-09-01T00:00:00Z